HALKUFF DAWN 4
4 · Xeris Biopharma Holdings, Inc. · Filed Jun 9, 2022
Insider Transaction Report
Form 4
HALKUFF DAWN
Director
Transactions
- Award
Common Stock
2022-06-08+15,000→ 15,000 total - Award
Stock Option (Right to Buy)
2022-06-08+25,000→ 25,000 totalExercise: $2.10From: 2022-06-08Exp: 2032-06-08→ Common Stock (25,000 underlying)
Footnotes (2)
- [F1]These shares were acquired pursuant to a restricted stock unit award under the Company's 2018 Stock Option and Incentive Plan. Each restricted stock represents a contingent right to receive one share of the Company's common stock. These shares shall vest in full upon the earlier to occur of June 8, 2023 or the date of the Company's next annual meeting of stockholders.
- [F2]Such options will vest in full upon the earlier to occur of June 8, 2023 or the date of the Company's next annual meeting of stockholders.